Drug expenditure in the Canadian province of British Columbia doubled between 1996 and 2003, and 80% of this increase was due to me-too drugs -- drugs that don't offer substantial improvements over less expensive alternatives already on the market. Details available in the BMJ.
Posted by schwitz at October 7, 2005 03:27 PM | TrackBack